Life Summary
Lee Don-haeng is the CEO of Nextbiomedical.

He founded the company while working as a doctor and has continued to practice medicine even after its establishment.

He was born on February 28, 1963.

He graduated from Yonsei University with a degree in medicine and earned both his master's and doctoral degrees in internal medicine from Yonsei University Graduate School.

He joined Inha University Hospital as an assistant professor in the Department of Gastroenterology and served as co-director of the Utah-Inha DDS Joint Research Center and director of the Biomedical Research Institute.

In 2014, he founded Nextbiomedical and launched the NexPowder business, an endoscopic hemostatic agent.

He served as the director of the National Designated Gastrointestinal Disease Efficacy Evaluation Center.

He aims to develop endoscopic hemostatic agents, vascular embolic microspheres, and musculoskeletal pain embolization treatments to establish the company as a leading global polymer therapeutics firm.

#LeeDonhaeng #Nextbiomedical #medicalstartup #biotechnology #gastroenterology #endoscopy #hemostaticagent #vascularembolization #polymertherapeutics #medicalinnovation